July 13, 2020

The Niche

Knoepfler lab stem cell blog

Who deserves patent for CRISPR-Cas9 in human cells? Take our poll

There is no hotter technology than CRISPR-Cas9 gene editing tools.

Perhaps it is not surprising then that there is a patent dispute over it, which falls into two camps:

(1) Jennifer Doudna & Emmanuelle Charpentier, and (2) Feng Zhang.

Who deserves the intellectual property for use of CRISPR-Cas9 in human cells?

Take our poll.

%d bloggers like this: